Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock

1.464 EUR
+0 (+0.14%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALTUV scores 4 out of 10 in our fundamental rating. ALTUV was compared to 109 industry peers in the Machinery industry. ALTUV has only an average score on both its financial health and profitability. ALTUV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ALTUV was profitable.
ALTUV had a positive operating cash flow in the past year.
In the past 5 years ALTUV has always been profitable.
ALTUV had a positive operating cash flow in 4 of the past 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

ALTUV's Return On Assets of 1.37% is on the low side compared to the rest of the industry. ALTUV is outperformed by 65.14% of its industry peers.
ALTUV's Return On Equity of 2.44% is on the low side compared to the rest of the industry. ALTUV is outperformed by 67.89% of its industry peers.
ALTUV's Return On Invested Capital of 2.84% is on the low side compared to the rest of the industry. ALTUV is outperformed by 72.48% of its industry peers.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.90%. This is significantly below the industry average of 8.95%.
Industry RankSector Rank
ROA 1.37%
ROE 2.44%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ALTUV's Profit Margin of 2.64% is in line compared to the rest of the industry. ALTUV outperforms 42.20% of its industry peers.
ALTUV's Profit Margin has declined in the last couple of years.
ALTUV's Operating Margin of 5.92% is in line compared to the rest of the industry. ALTUV outperforms 45.87% of its industry peers.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
Looking at the Gross Margin, with a value of 38.14%, ALTUV is in line with its industry, outperforming 45.87% of the companies in the same industry.
ALTUV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.92%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
Compared to 1 year ago, ALTUV has about the same amount of shares outstanding.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALTUV has an Altman-Z score of 1.42. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.42, ALTUV is not doing good in the industry: 67.89% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALTUV is 7.66, which is on the high side as it means it would take ALTUV, 7.66 years of fcf income to pay off all of its debts.
ALTUV's Debt to FCF ratio of 7.66 is in line compared to the rest of the industry. ALTUV outperforms 43.12% of its industry peers.
ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
ALTUV has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.66
Altman-Z 1.42
ROIC/WACC0.4
WACC7.12%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.07 indicates that ALTUV has no problem at all paying its short term obligations.
ALTUV has a better Current ratio (2.07) than 77.98% of its industry peers.
A Quick Ratio of 1.33 indicates that ALTUV should not have too much problems paying its short term obligations.
The Quick ratio of ALTUV (1.33) is better than 75.23% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.33
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
The Revenue has decreased by -7.99% in the past year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.91, which indicates a rather expensive current valuation of ALTUV.
Based on the Price/Earnings ratio, ALTUV is valued a bit cheaper than 63.30% of the companies in the same industry.
ALTUV is valuated rather cheaply when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.21, which indicates a correct valuation of ALTUV.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit cheaper than 62.39% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, ALTUV is valued a bit cheaper.
Industry RankSector Rank
PE 20.91
Fwd PE 14.21
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTUV is valued a bit cheaper than the industry average as 64.22% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaply inside the industry as 81.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.56
EV/EBITDA 8.72
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%

3

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 1.56, ALTUV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, ALTUV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (12/29/2025, 7:00:00 PM)

1.464

+0 (+0.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-18 2025-09-18
Earnings (Next)01-22 2026-01-22/amc
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.72M
Revenue(TTM)37.81M
Net Income(TTM)1.00M
Analysts86.67
Price Target3.06 (109.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.91
Fwd PE 14.21
P/S 0.55
P/FCF 7.56
P/OCF 4.34
P/B 0.51
P/tB 4.22
EV/EBITDA 8.72
EPS(TTM)0.07
EY4.78%
EPS(NY)0.1
Fwd EY7.04%
FCF(TTM)0.19
FCFY13.23%
OCF(TTM)0.34
OCFY23.03%
SpS2.67
BVpS2.9
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.14
Profitability
Industry RankSector Rank
ROA 1.37%
ROE 2.44%
ROCE 3.86%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.49%
OM 5.92%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.25%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
ROICexc(3y)4.1%
ROICexc(5y)3.43%
ROICexgc(3y)16.63%
ROICexgc(5y)12.76%
ROCE(3y)5.32%
ROCE(5y)4.17%
ROICexgc growth 3Y36.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.71%
ROICexc growth 5YN/A
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.66
Debt/EBITDA 3.36
Cap/Depr 79.92%
Cap/Sales 5.37%
Interest Coverage 250
Cash Conversion 99.79%
Profit Quality 274%
Current Ratio 2.07
Quick Ratio 1.33
Altman-Z 1.42
F-Score7
WACC7.12%
ROIC/WACC0.4
Cap/Depr(3y)64.39%
Cap/Depr(5y)89.92%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6706.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.27%
EBIT growth 3Y28.77%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.4%
FCF growth 3Y105.48%
FCF growth 5YN/A
OCF growth 1Y18.95%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status for ALTUV stock?

ChartMill assigns a valuation rating of 5 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


What is the profitability of ALTUV stock?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


How financially healthy is BIO-UV GROUP SAS?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.


What is the earnings growth outlook for BIO-UV GROUP SAS?

The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.